Starfish Bioscience is a technology company.
Starfish Bioscience has raised $970K across 1 funding round.
Starfish Bioscience has raised $970K in total across 1 funding round.
Starfish Bioscience has raised $970K in total across 1 funding round.
Starfish Bioscience's investors include Ankur Capital, Seventure Partners.
Starfish Bioscience is a French technology company specializing in the development of next-generation microbiological biosolutions aimed at restoring soil fertility by regenerating soil microbiomes, primarily for agriculture and viticulture. Their patented products focus on sustainable soil health, reducing chemical inputs, and improving crop resilience against stresses such as pathogens and drought. The company serves agribusinesses and farmers, addressing critical challenges in soil degradation and sustainability while contributing to environmental preservation and agricultural productivity. Since its founding in 2023, Starfish Bioscience has gained momentum through innovative AI-driven microbiome mapping and partnerships with investors like Seventure Partners and IRDI Capital[1][2][3][4].
Founded in 2023 by Sandrine Claus, who serves as CEO, Starfish Bioscience emerged from the recognition of the crucial role soil microbiomes play in ecosystem health and sustainable agriculture. Claus and her team identified the degradation of microbial biodiversity in agricultural soils, especially in vineyards, due to intensive farming practices and chemical use. The company’s early pivotal work involved creating the first comprehensive soil bacteria atlas for Bordeaux vineyards, analyzing over 10,000 bacterial genomes with AI to identify keystone bacteria essential for soil regeneration. This foundational research positioned Starfish Bioscience as a pioneer in microbiome-based biostimulants, aligning with EU policies on soil regeneration and tapping into the growing global biostimulant market[1][2][3][4].
Starfish Bioscience rides the growing global trend toward sustainable agriculture and soil health restoration, a sector driven by increasing environmental regulations and consumer demand for eco-friendly farming. The timing is critical as the global biostimulant market is projected to grow at a 15.3% CAGR through 2032, with Europe representing half of the consumption. Their AI-driven microbiome mapping and region-specific microbial solutions position them at the forefront of precision agriculture technologies. By restoring soil microbial ecosystems, they contribute to climate resilience, biodiversity preservation, and reduced chemical dependency, influencing the broader ecosystem of agri-tech innovation and sustainable food systems[2][3].
Looking ahead, Starfish Bioscience plans to expand its microbiome mapping and biosolution development beyond Bordeaux to other key European agricultural regions such as Austria, Spain, and Italy. This geographic scaling will enable tailored microbial products that address local soil challenges, enhancing their market reach and impact. Trends shaping their journey include advances in AI for microbiome analysis, increasing regulatory support for sustainable farming, and rising demand for biostimulants. As they grow, Starfish Bioscience is poised to deepen its influence in the agri-tech sector by driving soil health innovation and supporting the transition to regenerative agriculture, reinforcing their mission to improve global agricultural sustainability[3][4].
Starfish Bioscience has raised $970K across 1 funding round. Most recently, it raised $970K Seed in February 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2024 | $970K Seed | Ankur Capital, Seventure Partners |